1978
DOI: 10.1097/00003081-197821040-00014
|View full text |Cite
|
Sign up to set email alerts
|

Extramammary Pagetʼs Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
9
0
1

Year Published

1981
1981
2010
2010

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(10 citation statements)
references
References 0 publications
0
9
0
1
Order By: Relevance
“…The weight of evidence supports a glandular origin for extramammary Paget's disease. Several series have demonstrated positive immunostaining in Paget cells in contrast to negative intervening keratinocytes and melanocytes 11,12 . We found this technique was particularly useful in identifying extramammary Paget cells alongside adjacent areas of intraepidermal dysplasia.…”
Section: Discussionmentioning
confidence: 75%
“…The weight of evidence supports a glandular origin for extramammary Paget's disease. Several series have demonstrated positive immunostaining in Paget cells in contrast to negative intervening keratinocytes and melanocytes 11,12 . We found this technique was particularly useful in identifying extramammary Paget cells alongside adjacent areas of intraepidermal dysplasia.…”
Section: Discussionmentioning
confidence: 75%
“…Eine Parallel zum Carcinoma in situ der Vulva ergibt sich in der Syntropie des Morbus Paget mit Zweitkarzinomen anderer Organe (Breen et al 1978;Creasman et al 1975;Fenn et al 1971;Fetherson und Friedrich 1972;Koss und Brockunier 1978;Lee et al 1977;Taylor et al 1975;Tsukada et al 1975). Diese wird in der Literatur mit 17-43% angegeben.…”
Section: Mpaget Der Vulvaunclassified
“…By contrast, vulvar Paget's disease with an underlying apocrine gland carcinoma has been regarded as an invasive malignancy and managed accordingly by a more radical treatment 1 . Moreover, vulvar Paget's disease in approximately 25% of the cases has been found to be associated with another prior or concomitant malignancy elsewhere in the body, especially breast carcinoma and squamous cell carcinoma of the vulva, uterus, cervix, and vagina 4 . Thus, screening procedures for these malignancies must become part of the routine evaluation of all patients with vulvar Paget's disease 5 …”
Section: Introductionmentioning
confidence: 99%